Chukwuweike U. Gwam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chukwuweike U. Gwam has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Ronald Emilio Delanois
Department of Orthopaedic Surgery, Greater Baltimore Medical Center Inc, Towson, Maryland, United States
12 shared publications - Michael Albert Mont
Department of Orthopaedic Surgery, The Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, USA
8 shared publications - Anton Khlopas
Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
7 shared publications - Morad Chughtai
Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, Ohio
7 shared publications Jaydev B Mistry
Department of Orthopedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY
5 shared publications- Nequesha S. Mohamed
Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland
5 shared publications
Latest Publications
- 9 February 2021
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 29 (7) , e337-e344
Addressing National Opioid Prescribing Practices for Knee Osteoarthritis: An Analysis of an Estimated 41,389,332 Patients With Knee Arthritis
Introduction: Knee osteoarthritis (OA) is a chronic pathology that is treated across multiple specialties. Opioid prescribing practices for knee OA have not been described on a national level. The purpose of this study was to (1) investigate the trends in opioid prescriptions for knee OA, (2) characterize and identify predominant opioid based medications prescribed for knee OA, and (3) identify patient- and provider-related factors influencing opioid prescribing patterns in the treatment of knee OA in the outpatient setting. Methods: The National Ambulatory Medical Care Survey (NAMCS) was used to identify all patients in the United States who presented to an outpatient clinic for knee OA between 2007 and 2016. New opioid prescriptions were determined using a previously published algorithm. Generalized linear models were used to assess trends. Results: A total of 41,389,332 patients were included, of which 12.8% were prescribed an opioid-based medication. Opioid prescription rose from 2007/2008 to 2013/2014. Analysis of the opioid type demonstrated that the prescription of hydrocodone-based medication and “other” traditional opioids followed the aforementioned trends. However, tramadol prescription demonstrated a sustained increase throughout the years peaking at 2015/2016. Patient income in the lowest quartile, a worker's compensation status, and depression were independently associated with higher odds of opioid prescription for knee OA. Conclusions: Opioid prescription for knee OA remains high. Decreases in traditional opioid prescription have been countered by increase in tramadol prescription. The risks and addictive potential of tramadol and patient and provider risk factors should be emphasized.
- 9 February 2021
- Published by Wolters Kluwer Health in Journal of the American Academy of Orthopaedic Surgeons
- Vol. 29 (7) , e337-e344
Addressing National Opioid Prescribing Practices for Knee Osteoarthritis: An Analysis of an Estimated 41,389,332 Patients With Knee Arthritis
Introduction: Knee osteoarthritis (OA) is a chronic pathology that is treated across multiple specialties. Opioid prescribing practices for knee OA have not been described on a national level. The purpose of this study was to (1) investigate the trends in opioid prescriptions for knee OA, (2) characterize and identify predominant opioid based medications prescribed for knee OA, and (3) identify patient- and provider-related factors influencing opioid prescribing patterns in the treatment of knee OA in the outpatient setting. Methods: The National Ambulatory Medical Care Survey (NAMCS) was used to identify all patients in the United States who presented to an outpatient clinic for knee OA between 2007 and 2016. New opioid prescriptions were determined using a previously published algorithm. Generalized linear models were used to assess trends. Results: A total of 41,389,332 patients were included, of which 12.8% were prescribed an opioid-based medication. Opioid prescription rose from 2007/2008 to 2013/2014. Analysis of the opioid type demonstrated that the prescription of hydrocodone-based medication and “other” traditional opioids followed the aforementioned trends. However, tramadol prescription demonstrated a sustained increase throughout the years peaking at 2015/2016. Patient income in the lowest quartile, a worker's compensation status, and depression were independently associated with higher odds of opioid prescription for knee OA. Conclusions: Opioid prescription for knee OA remains high. Decreases in traditional opioid prescription have been countered by increase in tramadol prescription. The risks and addictive potential of tramadol and patient and provider risk factors should be emphasized.
- Open Access
- 25 December 2019
- Published by Scientifica Press in Hong Kong Journal of Orthopaedic Research
- Vol. 2 (3) , 17-20
Accelerometer–measured physical activity levels before and after total hip arthroplasty: A cohort study
- 25 December 2019
- Published by Scientifica Press in Hong Kong Journal of Orthopaedic Research
- Vol. 2 (3) , 17-20
Open AccessAccelerometer–measured physical activity levels before and after total hip arthroplasty: A cohort study
- Open Access
- 25 December 2019
- Published by Scientifica Press in Hong Kong Journal of Orthopaedic Research
- Vol. 2 (3) , 01-05
After adjusting for preoperative confounders, is there an increased risk of perioperative complications in dialysis dependent total hip arthroplasty patients?
- 25 December 2019
- Published by Scientifica Press in Hong Kong Journal of Orthopaedic Research
- Vol. 2 (3) , 01-05
Open AccessAfter adjusting for preoperative confounders, is there an increased risk of perioperative complications in dialysis dependent total hip arthroplasty patients?
- Open Access
- 14 August 2019
- Published by Asociacion Argentina de Ortopedia y Traumatologia in Revista de la Asociación Argentina de Ortopedia y Traumatología
- Vol. 85 (1) , 82-90
El uso de plasma rico en plaquetas para desgarros musculares agudos: Revisión sistemática y meta-análisis de la evidencia actual. [The use of platelet rich plasma for acute muscle tears: Systematic review and meta-analysis of current evidence.]
Introducción El desgarro muscular agudo es el tipo de lesión más frecuente en actividades deportivas. Se ha tomado interés en busca de modalidades que reduzcan y mejoren el tiempo de curación. El uso de plasma rico en plaquetas (PRP) ha crecido en popularidad en los últimos años, pero dicha popularidad no fue acompañada de suficiente respaldo científico que avale su eficacia. Este estudio intenta recabar, analizar y sintetizar la información publicada para esclarecer los efectos del uso de PRP en desgarros musculares agudos mediante revisión sistemática y meta-análisis. Material y Métodos Se realizó una revisión sistemática de la literatura sobre el uso de PRP para el tratamiento de las lesiones musculares agudas. Un metanálisis fue conducido para evaluar los efectos del PRP. Resultados Siete artículos cumplieron los criterios de inclusión. Seis ensayos controlados aleatorizados y un estudio de cohorte. El tiempo total de retorno al deporte con PRP fue de una media de 29 días (rango, 10 a 50.9 días). En los grupos control fue una media de 35,4 días (rango, 22 a 52,8 días). El metanálisis demostró una diferencia significativa en el retorno deportivo con el uso de PRP en comparación con la terapia convencional (-7.80 días; p = 0.007). No se informaron diferencias en la tasa de recurrencia. Conclusión El metanálisis demostró un efecto favorable de PRP en comparación con la terapia convencional. Sin embargo, nuestro análisis demostró una heterogeneidad significativa en el estudio. Los resultados deben interpretarse con cautela. Aún no podemos recomendar el uso de PRP para el tratamiento de desgarros musculares agudos.
- 14 August 2019
- Published by Asociacion Argentina de Ortopedia y Traumatologia in Revista de la Asociación Argentina de Ortopedia y Traumatología
- Vol. 85 (1) , 82-90
Open AccessEl uso de plasma rico en plaquetas para desgarros musculares agudos: Revisión sistemática y meta-análisis de la evidencia actual. [The use of platelet rich plasma for acute muscle tears: Systematic review and meta-analysis of current evidence.]
Introducción El desgarro muscular agudo es el tipo de lesión más frecuente en actividades deportivas. Se ha tomado interés en busca de modalidades que reduzcan y mejoren el tiempo de curación. El uso de plasma rico en plaquetas (PRP) ha crecido en popularidad en los últimos años, pero dicha popularidad no fue acompañada de suficiente respaldo científico que avale su eficacia. Este estudio intenta recabar, analizar y sintetizar la información publicada para esclarecer los efectos del uso de PRP en desgarros musculares agudos mediante revisión sistemática y meta-análisis. Material y Métodos Se realizó una revisión sistemática de la literatura sobre el uso de PRP para el tratamiento de las lesiones musculares agudas. Un metanálisis fue conducido para evaluar los efectos del PRP. Resultados Siete artículos cumplieron los criterios de inclusión. Seis ensayos controlados aleatorizados y un estudio de cohorte. El tiempo total de retorno al deporte con PRP fue de una media de 29 días (rango, 10 a 50.9 días). En los grupos control fue una media de 35,4 días (rango, 22 a 52,8 días). El metanálisis demostró una diferencia significativa en el retorno deportivo con el uso de PRP en comparación con la terapia convencional (-7.80 días; p = 0.007). No se informaron diferencias en la tasa de recurrencia. Conclusión El metanálisis demostró un efecto favorable de PRP en comparación con la terapia convencional. Sin embargo, nuestro análisis demostró una heterogeneidad significativa en el estudio. Los resultados deben interpretarse con cautela. Aún no podemos recomendar el uso de PRP para el tratamiento de desgarros musculares agudos.
- 19 June 2019
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 101 (12) , e59
Procedure-Related Risk Factors May Be More Important in Predicting Length of Stay After Total Knee Arthroplasty
- 19 June 2019
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 101 (12) , e59
Procedure-Related Risk Factors May Be More Important in Predicting Length of Stay After Total Knee Arthroplasty
- 8 April 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 33 (08) , 745-749
Dialysis Is Not Associated with Increased Risk of Perioperative Complications in TKA Patients after Adjusting for Pertinent Confounders
With a growing prevalence for chronic renal failure, arthroplasty surgeons will find it more likely to have dialysis dependent patients present for knee replacement. Previous retrospective studies using a matched cohort of patients have reported worse perioperative outcomes for dialysis-dependent patients. However, many of these studies failed to control for pertinent confounders. This study aims to fill in that void. The present study compares lengths of stay, discharge status, and 30-day outcomes between dialysis-dependent TKA recipients and a matched cohort of nondialysis dependent TKA recipients. The National Surgical Quality Improvement Program database was used to identify the study cohorts. Patients were propensity score matched based on patient-specific demographic variables, preoperative functional status, and preoperative laboratory values. Generalized regression models were conducted to assess the effects of dialysis dependency on perioperative outcomes. Dialysis dependent patients demonstrated longer mean lengths of stay (+1.14) and a lower likelihood for home discharge (odds ratio [OR] = 0.503). There was no increased risk of 30-day complications in dialysis dependent TKA patients. Our findings demonstrate no increased risk of 30-day complications after TKA when adjusting for pertinent confounders. This suggests TKA is safe for well optimized dialysis dependent patients prior to surgery.
- 8 April 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 33 (08) , 745-749
Dialysis Is Not Associated with Increased Risk of Perioperative Complications in TKA Patients after Adjusting for Pertinent Confounders
With a growing prevalence for chronic renal failure, arthroplasty surgeons will find it more likely to have dialysis dependent patients present for knee replacement. Previous retrospective studies using a matched cohort of patients have reported worse perioperative outcomes for dialysis-dependent patients. However, many of these studies failed to control for pertinent confounders. This study aims to fill in that void. The present study compares lengths of stay, discharge status, and 30-day outcomes between dialysis-dependent TKA recipients and a matched cohort of nondialysis dependent TKA recipients. The National Surgical Quality Improvement Program database was used to identify the study cohorts. Patients were propensity score matched based on patient-specific demographic variables, preoperative functional status, and preoperative laboratory values. Generalized regression models were conducted to assess the effects of dialysis dependency on perioperative outcomes. Dialysis dependent patients demonstrated longer mean lengths of stay (+1.14) and a lower likelihood for home discharge (odds ratio [OR] = 0.503). There was no increased risk of 30-day complications in dialysis dependent TKA patients. Our findings demonstrate no increased risk of 30-day complications after TKA when adjusting for pertinent confounders. This suggests TKA is safe for well optimized dialysis dependent patients prior to surgery.
- 1 April 2019
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 34 (4) , 801-813
Biologic Therapies for the Treatment of Knee Osteoarthritis
- 1 April 2019
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 34 (4) , 801-813
Biologic Therapies for the Treatment of Knee Osteoarthritis
- 15 February 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 33 (04) , 378-386
The Who, What, and Where of Primary TKAs: An Analysis of HCUP Data from 2009 to 2015
The aim of this study was to assess (1) temporal trends, (2) primary indication, (3) patient-level demographics (age, race, gender, health status, and median income quartile), and (4) region and hospital type for all patients receiving primary total knee arthroplasty (TKA) between 2009 and the third quarter of 2015. The National Inpatient Sample Database (NIS) was used to identify all patients who underwent a TKA between 2009 and the third quarter of 2015. Regression analysis was utilized to assess trends. Chi-square analysis was used to explore categorical variables whereas Kruskal–Wallis test was used to explore nonparametric continuous variables. TKA utilization increased between 2009 and 2015 with the highest volume occurring during the fall. Primary osteoarthritis was the primary indication in 98% of cases. There was an increase in minority representation among recipients. Black TKA recipients were younger and had lower median age-adjusted Charlson's comorbidity index (CCI). Black recipients were most likely to be of the lowest 25% of median income than any other races. The Midwest demonstrated the greatest increase in TKAs performed per 100,000 between 2009 and 2014. Case volumes shifted to urban teaching hospitals between 2009 and 2014. There were differences in age of presentation, preoperative morbidity, and income status among races. Furthermore, our findings revealed a more rapid growth in TKA procedures per 100,000 in the Midwest, in addition to volume shifts toward urban teaching hospitals. Future studies are needed to update our findings as well as explore trends in racial disparities for primary TKA recipients.
- 15 February 2019
- Published by Georg Thieme Verlag KG in The Journal of Knee Surgery
- Vol. 33 (04) , 378-386
The Who, What, and Where of Primary TKAs: An Analysis of HCUP Data from 2009 to 2015
The aim of this study was to assess (1) temporal trends, (2) primary indication, (3) patient-level demographics (age, race, gender, health status, and median income quartile), and (4) region and hospital type for all patients receiving primary total knee arthroplasty (TKA) between 2009 and the third quarter of 2015. The National Inpatient Sample Database (NIS) was used to identify all patients who underwent a TKA between 2009 and the third quarter of 2015. Regression analysis was utilized to assess trends. Chi-square analysis was used to explore categorical variables whereas Kruskal–Wallis test was used to explore nonparametric continuous variables. TKA utilization increased between 2009 and 2015 with the highest volume occurring during the fall. Primary osteoarthritis was the primary indication in 98% of cases. There was an increase in minority representation among recipients. Black TKA recipients were younger and had lower median age-adjusted Charlson's comorbidity index (CCI). Black recipients were most likely to be of the lowest 25% of median income than any other races. The Midwest demonstrated the greatest increase in TKAs performed per 100,000 between 2009 and 2014. Case volumes shifted to urban teaching hospitals between 2009 and 2014. There were differences in age of presentation, preoperative morbidity, and income status among races. Furthermore, our findings revealed a more rapid growth in TKA procedures per 100,000 in the Midwest, in addition to volume shifts toward urban teaching hospitals. Future studies are needed to update our findings as well as explore trends in racial disparities for primary TKA recipients.